Dr. Joan Fallon of Curemark: 5 Things I Wish Someone Told Me Before I Became A CEO

Aspart of my series about the leadership lessons of accomplished business leaders, I had the pleasure of interviewing Dr. Joan Fallon, Founder and CEO of Curemark.

Dr. Joan Fallon is a scientist who has dedicated her life’s work to championing the health and wellbeing of children worldwide. Curemark is a biopharmaceutical company focused on the development of novel therapies to treat serious diseases for which there are limited treatment options. The company’s pipeline includes a phase III clinical-stage research program for Autism, as well as programs focused on Parkinson’s Disease, schizophrenia, and addiction.

Curemark will commence the filing of a Biological Drug Application for the first novel drug for Autism under the FDA Fast Track Program. Fast Track status is a designation given only to investigational new drugs that are intended to treat serious or life-threatening conditions and that have demonstrated the potential to address unmet medical needs.


Read the full article here.